fleischner calculator

What this Fleischner calculator does

This calculator gives a practical follow-up suggestion for incidental pulmonary nodules using the commonly referenced 2017 Fleischner Society recommendations. It takes a few key variables—nodule type, size, number of nodules, and risk profile—and translates them into a follow-up imaging pathway.

In real practice, final management still depends on radiologist interpretation, patient context, and shared clinical decision-making. Think of this as a structured starting point for review, documentation, and patient counseling.

When Fleischner guidance applies (and when it does not)

Generally applies to:

• Adults older than 35 years
• Incidentally detected lung nodules on CT
• Patients without a clear competing cancer explanation

Generally does not apply to:

• Patients in formal lung cancer screening programs (use Lung-RADS workflows)
• Immunocompromised patients (higher infection and atypical process risk)
• Patients with known active malignancy where metastasis is a concern
• Children and younger adults where prevalence and risk dynamics differ

How to interpret the key inputs

Nodule type

Solid nodules often use shorter interval follow-up thresholds at 6 mm and 8 mm. Ground-glass nodules may require longer surveillance windows due to slower growth behavior. Part-solid nodules are especially important because the size of the solid component may shift concern level significantly.

Single versus multiple nodules

Multiple nodules are often managed according to the most suspicious lesion, but interval timing can differ from single-nodule pathways. The calculator reflects this by changing recommendations when “multiple” is selected.

Risk profile

“High risk” usually includes stronger smoking exposure, suspicious margins, upper-lobe location, family history, or prior cancer concerns. “Low risk” means these factors are absent or limited. If you are unsure, use high risk and discuss with the treating clinician.

Quick practical pearls

• Nodules under 6 mm are often low concern, but high-risk contexts can still justify optional follow-up.
• Solid nodules above 8 mm often trigger early re-evaluation and possible PET-CT or tissue sampling.
• Persistent subsolid nodules may need multi-year surveillance, often up to 5 years.
• For part-solid nodules, the solid component is frequently the deciding factor for escalation.

Clinical limitations you should keep in mind

A calculator cannot read morphology details such as spiculation, internal fat, calcification pattern, perifissural appearance, interval growth rate, or scanner protocol differences. It also cannot integrate patient preferences, procedural risk tolerance, or local specialty availability.

For these reasons, recommendations here should be treated as an aid, not an endpoint. Whenever the result feels discordant with the radiology report or bedside picture, clinical judgment should override automation.

FAQ

Is this a diagnostic tool?

No. It is a follow-up planning aid based on guideline categories.

Can I use this for screening CT nodules?

Not ideally. Screening populations are usually managed with Lung-RADS rather than standard incidental pathways.

Why does age matter?

Guideline applicability and malignancy probability change substantially in younger populations, especially under age 35.

What if the recommendation says “consider PET/CT or biopsy”?

That indicates a higher concern tier where additional characterization is often appropriate. Next steps depend on pretest probability, comorbidities, and multidisciplinary assessment.